No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Phytogenic / adverse effects*
-
Antineoplastic Agents, Phytogenic / therapeutic use
-
Carcinoma / drug therapy
-
Carcinoma / epidemiology
-
Carcinoma / genetics*
-
Extracellular Matrix Proteins / genetics*
-
Female
-
GPI-Linked Proteins / genetics
-
Genetic Predisposition to Disease
-
Genome-Wide Association Study
-
Humans
-
Nervous System Diseases / chemically induced*
-
Nervous System Diseases / genetics*
-
Ovarian Neoplasms / drug therapy
-
Ovarian Neoplasms / epidemiology
-
Ovarian Neoplasms / genetics*
-
Paclitaxel / adverse effects*
-
Paclitaxel / therapeutic use
-
Polymorphism, Single Nucleotide / physiology
-
Reproducibility of Results
-
Retrospective Studies
-
Scandinavian and Nordic Countries / epidemiology
-
Validation Studies as Topic
Substances
-
Antineoplastic Agents, Phytogenic
-
Extracellular Matrix Proteins
-
GPI-Linked Proteins
-
TECTA protein, human
-
Paclitaxel